• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苦瓜与帕唑帕尼的危险相互作用:一例急性胰腺炎。

Dangerous interaction of bitter melon () with pazopanib: A case of acute pancreatitis.

机构信息

Department of Medical Oncology, 64001Gazi University Faculty of Medicine, Ankara, Turkey.

出版信息

J Oncol Pharm Pract. 2022 Mar;28(2):486-488. doi: 10.1177/10781552211040725. Epub 2021 Sep 27.

DOI:10.1177/10781552211040725
PMID:34569860
Abstract

INTRODUCTION

Acute pancreatitis associated with Pazopanib has been reported in the literature. Bitter Melon (Momordica Charantia) is traditionally used as a folk medicine in many regions. In this report, we describe a 65-year-old patient with a diagnosis of renal cell carcinoma, admitted to the hospital with symptoms of acute pancreatitis at the 8th year of pazopanib treatment.

CASE REPORT

The patient diagnosed with renal cell carcinoma was admitted to the hospital with the complaint of abdominal pain, nausea, and vomiting in the 8th year of Pazopanib treatment. It was noticed from the patient's history that he had received Bitter Melon extract for 4 days prior to the beginning of his complaints (100-150 ml/day). Levels of serum amylase and lipase were measured as 9163 U/L and 14,206 U/L, respectively.

MANAGEMENT & OUTCOME: Pazopanib drug was held. The patient was treated for acute pancreatitis. Pazopanib treatment was started again after the clinical condition of the patient had improved and levels of serum amylase and lipase had returned to normal levels. Levels of serum amylase and lipase did not increase again after re-administration of pazopanib treatment.

DISCUSSION

It is thought that Bitter Melon extract and pazopanib interaction might have led to acute pancreatitis. To the best of our knowledge, this case is the first to highlight the interaction of Bitter Melon extract with pazopanib. The Drug Interaction Probability Scale indicates that there is a probable association between bitter melon and acute pancreatitis.

摘要

简介

文献中报道了与帕唑帕尼相关的急性胰腺炎。苦瓜(Momordica charantia)在许多地区传统上被用作民间药物。在本报告中,我们描述了一位 65 岁的患者,该患者被诊断患有肾细胞癌,在接受帕唑帕尼治疗的第 8 年因急性胰腺炎住院。

病例报告

该患者被诊断患有肾细胞癌,在接受帕唑帕尼治疗的第 8 年因腹痛、恶心和呕吐而住院。从患者的病史中注意到,在出现症状前 4 天他曾服用苦瓜提取物(100-150ml/天)。血清淀粉酶和脂肪酶的水平分别为 9163U/L 和 14206U/L。

治疗和结果

暂停帕唑帕尼药物。对患者进行了急性胰腺炎治疗。在患者的临床状况改善且血清淀粉酶和脂肪酶水平恢复正常后,重新开始帕唑帕尼治疗。重新开始帕唑帕尼治疗后,血清淀粉酶和脂肪酶水平没有再次升高。

讨论

据认为,苦瓜提取物和帕唑帕尼的相互作用可能导致了急性胰腺炎。据我们所知,这是首例强调苦瓜提取物与帕唑帕尼相互作用的案例。药物相互作用概率量表表明,苦瓜与急性胰腺炎之间存在可能的关联。

相似文献

1
Dangerous interaction of bitter melon () with pazopanib: A case of acute pancreatitis.苦瓜与帕唑帕尼的危险相互作用:一例急性胰腺炎。
J Oncol Pharm Pract. 2022 Mar;28(2):486-488. doi: 10.1177/10781552211040725. Epub 2021 Sep 27.
2
An autopsy case of severe acute pancreatitis induced by administration of pazopanib following nivolumab.一例在使用纳武单抗后服用帕唑帕尼诱发的严重急性胰腺炎尸检病例。
Pancreatology. 2021 Jan;21(1):21-24. doi: 10.1016/j.pan.2020.11.002. Epub 2020 Nov 5.
3
Bitter melon (Momordica charantia): a review of efficacy and safety.苦瓜(苦瓜属):疗效与安全性综述
Am J Health Syst Pharm. 2003 Feb 15;60(4):356-9. doi: 10.1093/ajhp/60.4.356.
4
Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.苦瓜在 2 型糖尿病患者中的降糖疗效和安全性。
Complement Ther Med. 2020 Aug;52:102524. doi: 10.1016/j.ctim.2020.102524. Epub 2020 Jul 22.
5
Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.苦瓜(Momordica charantia)生物活性物质在癌症预防和治疗中的前景。
Semin Cancer Biol. 2016 Oct;40-41:116-129. doi: 10.1016/j.semcancer.2016.07.002. Epub 2016 Jul 21.
6
Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.苦瓜提取物对果糖喂养大鼠胰岛素抵抗及骨骼肌葡萄糖转运蛋白4(GLUT4)的影响
J Ethnopharmacol. 2009 May 4;123(1):82-90. doi: 10.1016/j.jep.2009.02.039. Epub 2009 Mar 6.
7
Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.改善苦瓜(苦瓜)口感和增加消费意愿的策略:一种常用于糖尿病管理的蔬菜。
Nutr J. 2011 Jul 28;10:78. doi: 10.1186/1475-2891-10-78.
8
Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.苦瓜(苦瓜属)提取物通过靶向AMPK信号级联抑制卵巢癌细胞的致瘤性并克服顺铂耐药性。
Integr Cancer Ther. 2016 Sep;15(3):376-89. doi: 10.1177/1534735415611747. Epub 2015 Oct 19.
9
Metabolite profiling and in vitro biological activities of two commercial bitter melon (Momordica charantia Linn.) cultivars.两种商业苦瓜(Momordica charantia Linn.)品种的代谢产物分析及体外生物活性研究。
Food Chem. 2019 Aug 1;288:178-186. doi: 10.1016/j.foodchem.2019.02.120. Epub 2019 Mar 2.
10
Investigation of Biological Activities of Wild Bitter Melon ( Linn. Var. Abbreviata Ser.).野生苦瓜(Linn. Var. Abbreviata Ser.)生物活性的研究。
Biomolecules. 2019 May 30;9(6):211. doi: 10.3390/biom9060211.

引用本文的文献

1
Therapeutic Potential of Momordicine I from : Cardiovascular Benefits and Mechanisms.苦瓜素 I 的治疗潜力:心血管益处和机制。
Int J Mol Sci. 2024 Sep 29;25(19):10518. doi: 10.3390/ijms251910518.
2
Safety Aspects of Herb Interactions: Current Understanding and Future Prospects.草药相互作用的安全性问题:当前认识与未来展望。
Curr Drug Metab. 2024;25(1):28-53. doi: 10.2174/0113892002289753240305062601.